Noonan Syndrome
Also known as: Other congenital malformation syndromes predominantly associated with short stature / Turner's phenotype, karyotype normal (disorder) / Noonan's syndrome (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00052 | Somatotropin | A recombinant human growth hormone used as replacement therapy in various conditions of growth failure, growth hormone deficiency, and weakness in children and adults. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB00052 | Somatotropin | Growth hormone receptor | target |
| DB00052 | Somatotropin | Prolactin receptor | target |
| DB00052 | Somatotropin | Cytochrome P450 1A2 | enzyme |
| DB00052 | Somatotropin | Cytochrome P450 2C19 | enzyme |
| DB00052 | Somatotropin | P-glycoprotein 1 | transporter |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB05897 | rhIGFBP-3 | 2 | Terminated | 1 |
| DB00641 | Simvastatin | 3 | Completed | 1 |
| DB15093 | Somapacitan | 3 | Recruiting | 1 |
| DB00052 | Somatotropin | 3 | Completed | 4 |
| DB00052 | Somatotropin | Not Available | Completed | 2 |
| DB00052 | Somatotropin | Not Available | Enrolling by Invitation | 1 |